High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: High rates of rapid cytogenetic and molecular responses

Jorge E. Cortes, Hagop M. Kantarjian, Stuart L. Goldberg, Bayard L. Powell, Francis J. Giles, Meir Wetzler, Luke Akard, John M. Burke, Robert Kerr, Mansoor Saleh, August Salvado, Karen McDougall, Maher Albitar, Jerald Radich

Research output: Contribution to journal › Article › peer-review